Fmoc-S-xanthyl-L-cysteine is an Fmoc-protected L-cysteine derivative in which the cysteine thiol is masked as a xanthyl thioether, yielding an amino acid building block with a thioether side chain rather than a free sulfhydryl. The molecule contains an N-terminal 9H-fluorenylmethoxycarbonyl (Fmoc) carbamate and a C-terminal carboxylic acid, while the side-chain sulfur bears the xanthyl group that modulates nucleophilicity and chemoselectivity during peptide assembly. It is employed as a protected amino acid for stepwise peptide synthesis and related chemical biology workflows where controlled thiol chemistry, thiol-masked stability, and incorporation of a cysteine-like residue with a defined sulfur functionality are required.
CAT No: CP00637
Fmoc-S-xanthyl-L-cysteine is an Fmoc-protected L-cysteine derivative in which the thiol side chain is converted to an S-xanthyl thioether, retaining the α-amino stereocenter of the parent amino acid while incorporating a bulky, aromatic sulfur substituent. The molecule contains an Fmoc carbamate for N-protection, a free carboxylate functionality appropriate for peptide coupling after activation, and a thioether sulfur that modulates nucleophilicity and steric accessibility relative to unprotected cysteine. The xanthyl group is designed to behave as a removable sulfur-protecting strategy under conditions compatible with peptide synthesis workflows, enabling later formation of cysteine-derived functionalities. The combination of a stable N-protecting group and a sulfur-protecting thioether makes this compound a chiral, structure-defined intermediate for controlled peptide and side-chain functionalization chemistry.
1. Protected Cysteine Peptide Synthesis
Fmoc-S-xanthyl-L-cysteine is used in peptide building workflows where cysteine side-chain protection is required to prevent undesired thiol oxidation, disulfide scrambling, or side reactions during chain assembly. The Fmoc carbamate enables standard N-Fmoc deprotection and subsequent coupling chemistry, while the S-xanthyl thioether protects the sulfur functionality without requiring immediate thiol handling. The defined stereochemistry of the L-cysteine backbone supports stereochemically consistent peptide bond formation and downstream cysteine-derived modifications after sulfur deprotection or transformation. The resulting peptide products can be carried into applications requiring controlled cysteine reactivity, including native-like cysteine incorporation and site-specific functionalization strategies.
2. Side-Chain Functionalization Chemistry
Fmoc-S-xanthyl-L-cysteine serves as a chiral sulfur-functional amino acid intermediate for side-chain derivatization routes that start from a protected thioether and end with thiol or thiol-derived motifs. The S-xanthyl group provides a handle for tuning sulfur reactivity and can be selected to manage chemoselectivity during sequential transformations, including conversion to reactive thiols, thioether exchange, or preparation of cysteine analogs for conjugation. The presence of the Fmoc group supports orthogonal protection logic, allowing selective deprotection of the nitrogen functionality while maintaining sulfur protection until the intended stage. Downstream intermediates generated from this chemistry can feed into peptidomimetic scaffolds, labeled cysteine-containing fragments, and structured electrophile/nucleophile pairs used in synthetic organic chemistry.
3. Chemical Biology And Conjugation
Fmoc-S-xanthyl-L-cysteine is applicable to chemical biology workflows that require defined cysteine positions for controlled biomolecule modification and probe construction. The protected amino acid format supports incorporation into peptides or peptide-like conjugates where the thiol reactivity must be masked during synthesis and unmasked at a later stage for conjugation chemistry. The sulfur-protecting thioether geometry helps manage oxidation state during handling and enables reproducible generation of thiol-containing derivatives for subsequent coupling to maleimides, haloacetamides, or other thiol-reactive electrophiles when compatible conditions are selected. The Fmoc-based assembly route also supports preparation of multivalent or sequence-defined conjugates used for studying molecular recognition, binding-site accessibility, and cysteine-dependent reactivity in biochemical assays.
4. Peptidomimetics And SAR Studies
Fmoc-S-xanthyl-L-cysteine can be employed in peptidomimetic construction where cysteine-containing motifs are embedded into constrained scaffolds for structure-activity relationship studies. The amino acid backbone, protected as an Fmoc carbamate, supports incorporation into analogs via peptide coupling chemistry, while the S-xanthyl thioether allows the sulfur functionality to remain controlled during scaffold assembly. The stereochemical fidelity of the L-configuration supports faithful mimicry of side-chain orientation relative to native cysteine, which can be important for conformational effects and interaction patterns. The resulting cysteine-bearing peptidomimetics can be used to generate structure-defined libraries and to support SAR investigations that correlate side-chain sulfur state with binding or reactivity profiles.
5. Process Chemistry Intermediate Preparation
Fmoc-S-xanthyl-L-cysteine is suitable for process chemistry intermediate preparation where orthogonally protected amino acid building blocks are required for scalable peptide and functional molecule manufacturing. The combination of Fmoc N-protection and S-xanthyl sulfur protection supports a controlled protection-deprotection sequence, reducing the need for direct handling of free thiols during upstream synthesis and purification. The stable, chiral amino acid framework can be integrated into manufacturing routes that rely on repeatable coupling steps and predictable protecting-group behavior across batch operations. Downstream, the compound can serve as a defined chiral intermediate for producing cysteine-containing peptide fragments, specialty fine chemicals, and sulfur-functional intermediates that feed into larger-scale synthetic programs.
1. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry
3. Cationic cell-penetrating peptides are potent furin inhibitors
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.